DK0610447T3 - CDw52-specifikt antistof til behandling af T-cellemedieret inflammation af leddene - Google Patents

CDw52-specifikt antistof til behandling af T-cellemedieret inflammation af leddene

Info

Publication number
DK0610447T3
DK0610447T3 DK93908763T DK93908763T DK0610447T3 DK 0610447 T3 DK0610447 T3 DK 0610447T3 DK 93908763 T DK93908763 T DK 93908763T DK 93908763 T DK93908763 T DK 93908763T DK 0610447 T3 DK0610447 T3 DK 0610447T3
Authority
DK
Denmark
Prior art keywords
treatment
joints
cdw52
cell mediated
mediated inflammation
Prior art date
Application number
DK93908763T
Other languages
English (en)
Inventor
Herman Waldmann
Geoffrey Hale
Original Assignee
Btg Int Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB929215749A external-priority patent/GB9215749D0/en
Application filed by Btg Int Ltd filed Critical Btg Int Ltd
Application granted granted Critical
Publication of DK0610447T3 publication Critical patent/DK0610447T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2893—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against CD52
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Biophysics (AREA)
  • Rheumatology (AREA)
  • Transplantation (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pain & Pain Management (AREA)
  • Biochemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Steroid Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DK93908763T 1991-10-15 1992-10-14 CDw52-specifikt antistof til behandling af T-cellemedieret inflammation af leddene DK0610447T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US77559891A 1991-10-15 1991-10-15
GB929215749A GB9215749D0 (en) 1992-07-24 1992-07-24 Medicaments
PCT/GB1992/001884 WO1993007899A1 (en) 1991-10-15 1992-10-14 CDw52 - SPECIFIC ANTIBODY FOR TREATMENT OF T-CELL MEDIATED INFLAMMATION OF THE JOINTS

Publications (1)

Publication Number Publication Date
DK0610447T3 true DK0610447T3 (da) 1999-08-23

Family

ID=26301317

Family Applications (1)

Application Number Title Priority Date Filing Date
DK93908763T DK0610447T3 (da) 1991-10-15 1992-10-14 CDw52-specifikt antistof til behandling af T-cellemedieret inflammation af leddene

Country Status (12)

Country Link
EP (1) EP0610447B1 (da)
JP (1) JP3535155B2 (da)
KR (1) KR100264218B1 (da)
AT (1) ATE174515T1 (da)
AU (1) AU671807B2 (da)
CA (1) CA2120911A1 (da)
DE (1) DE69227918T2 (da)
DK (1) DK0610447T3 (da)
ES (1) ES2125977T3 (da)
IL (1) IL103418A (da)
MY (1) MY115415A (da)
WO (1) WO1993007899A1 (da)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9022545D0 (en) 1990-10-17 1990-11-28 Wellcome Found Culture medium
GB9022543D0 (en) * 1990-10-17 1990-11-28 Wellcome Found Antibody production
GB9603507D0 (en) 1996-02-20 1996-04-17 Isis Innovation Antibody variants
GB2380127A (en) 2001-09-26 2003-04-02 Isis Innovation Treatment of chronic joint inflammation
SG10201806573TA (en) * 2012-05-25 2018-09-27 Cellectis Methods for engineering allogeneic and immunosuppressive resistant t cell for immunotherapy

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1339198C (en) * 1988-02-12 1997-08-05 Gregory Paul Winter Antibodies to the antigen campath-1
JPH05502586A (ja) * 1989-12-27 1993-05-13 セントカー・インコーポレーテツド Ｃｄ４受容体に対するキメラ免疫グロブリン
GB9022547D0 (en) * 1990-10-17 1990-11-28 Wellcome Found Purified immunoglobulin

Also Published As

Publication number Publication date
JP3535155B2 (ja) 2004-06-07
DE69227918T2 (de) 1999-05-12
KR100264218B1 (ko) 2000-08-16
IL103418A (en) 1997-11-20
EP0610447A1 (en) 1994-08-17
DE69227918D1 (de) 1999-01-28
CA2120911A1 (en) 1993-04-29
MY115415A (en) 2003-06-30
IL103418A0 (en) 1993-03-15
ATE174515T1 (de) 1999-01-15
ES2125977T3 (es) 1999-03-16
JPH07500330A (ja) 1995-01-12
AU671807B2 (en) 1996-09-12
WO1993007899A1 (en) 1993-04-29
AU2698592A (en) 1993-05-21
EP0610447B1 (en) 1998-12-16

Similar Documents

Publication Publication Date Title
DK0616537T3 (da) CDw52-specifikt antistof til behandling af dissemineret sclerose
ATE197316T1 (de) Monoklonale antikörper gegen definiierte regionen des t-zell-antigenrezeptors
ATE233814T1 (de) Humaner neutralisierender monoklonaler antikörper gegen den die immunschwäche beim menschen hervorringenden virus
LU92048I2 (fr) Tocilizumab
EP1266965A3 (en) Recombinant antibodies for human therapy
ES2106195T3 (es) Anticuerpo igg aglicosilado anti cd3.
WO1996020277A3 (en) Recombinant monoclonal anti-idiotype antibody 3h1 sequences relating to human carcinoembryonic antigen
DE69532889D1 (de) Interleukin-5-spezifische rekombinante antikörper
ATE248192T1 (de) HUMANISIERTE ANTIKÖRPER DIE AN DAS GLEICHE ANTIGEN WIE ANTIKÖRPER NR-LU-13 BINDEN UND DEREN VERWENDUNG IN ßPRETARGETINGß VERFAHREN
ITRM920457A0 (it) Anticorpi monoclonali che riconoscono un epitopo della p-glicoproteinaumana.
EA200400930A1 (ru) Блокирующее моноклональное антитело к vla-1 или его применение для лечения воспалительных заболеваний
ES2165506T3 (es) Antagonistas del il-8 para el tratamiento del asma.
DE69227918D1 (de) VERWENDUNG EINES CDw52-SPEZIFISCHEN ANTIKÖRPERS ZUR BEHANDLUNG VON DURCH T-ZELLEN VERMITTELTEN GELENKENTZÜNDUNGEN
NO981272L (no) Humanisert anti-human-Fas-antistoff
AU584690B2 (en) E87ag antigen of pseudomonas aeruginosa, monoclonal antibody against it, and hybridoma
NO972522L (no) Monoklonale antistoffer med immunoundertrykkende aktivitet
SE8702734D0 (sv) Monoclonal antibodies to pseudomonas aeruginosa flagella
ATE184315T1 (de) Neuartiges endothelzell-molekül, das die bindung von lymphozyten im menschen vermittelt
OA06652A (fr) Dispositif pour le raccordement étanche de deux tronçons cylindriques creux tels que tuyaux, éléments de raccords et analogues.
EA200101271A1 (ru) Блокирующее моноклональное антитело к vla-1 и его применение для лечения воспалительных заболеваний
ITRM920223A0 (it) Anticorpi monoclonali anti-idiopici diretti contro anticorpi anti-tnf.
EP0450573A3 (en) Antibodies for the treatment and diagnosis of pseudomonas aeruginosa infections
DK0574461T4 (da) Humaniserede, monoklonale höjaffinitetsantistoffer
ATE169332T1 (de) Monoklonaler antikörper gegen den extravillösen trophoblast
HUP9903273A3 (en) Anti-human mp52 monoclonal antibody